Investors & Media
We are a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients . Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, we aim to effectively drug protein targets that have previously been intractable. Our Dynamo platform integrates an array of leading-edge experimental and computational approaches to provide a differentiated understanding of protein structure and motion to drug these targets. Our initial focus is on enhancing small molecule therapeutic discovery in targeted oncology.
Data Provided by Refinitiv. Minimum 15 minutes delayed.